Alpha-1 Antitrypsin Deficiency Treatment Receives Orphan Drug Designation
source: pixabay.com

Alpha-1 Antitrypsin Deficiency Treatment Receives Orphan Drug Designation

  In June 2019, Dicerna Pharmaceuticals submitted a clinical trial application for their DCR-A1AT therapy and expects to treat the first patient with A1AD-related liver disease near the end of…

Continue Reading Alpha-1 Antitrypsin Deficiency Treatment Receives Orphan Drug Designation
It Just Makes “Antisense:” Using Genetic Medicine to Treat Rare Diseases
source: pixabay.com

It Just Makes “Antisense:” Using Genetic Medicine to Treat Rare Diseases

  As previously published in Scientific American, slightly after her first birthday, Emma Larson lost the use of her legs and started experiencing difficulty crawling. She was diagnosed with spinal muscular…

Continue Reading It Just Makes “Antisense:” Using Genetic Medicine to Treat Rare Diseases
Mother of Two Immunocompromised Children Offers Biggest Advice for Surviving COVID-19
source: pixabay.com

Mother of Two Immunocompromised Children Offers Biggest Advice for Surviving COVID-19

  Mother of two, Mina Manchester, has been navigating raising two children with an immunocompromising disorder for four years. It's this unique experience that makes her feel more prepared and…

Continue Reading Mother of Two Immunocompromised Children Offers Biggest Advice for Surviving COVID-19
Experimental Treatment for Cryopyrin-Associated Periodic Syndrome (CAPS) Shows Potential in Early Trial
source: pixabay.com

Experimental Treatment for Cryopyrin-Associated Periodic Syndrome (CAPS) Shows Potential in Early Trial

According to a story from Financial Buzz, the biotechnology company Inflazome recently announced that it has completed a phase 1 clinical trial. This trial was testing the company's experimental treatment…

Continue Reading Experimental Treatment for Cryopyrin-Associated Periodic Syndrome (CAPS) Shows Potential in Early Trial

Immunocompromised During COVID-19? Not Much Has Changed in the Lives of Many Rare Patients

Relapsing polychondritis is a rare disease which causes damage to the cartilage, trachea, and lungs. It's an autoimmune condition meaning an overzealous immune response causes the body to attack its own…

Continue Reading Immunocompromised During COVID-19? Not Much Has Changed in the Lives of Many Rare Patients

Study Highlights Need to Support Youth Acting as Amyotrophic Lateral Sclerosis Caregivers

A recent study, conducted my Melinda Kavanaugh from the University of Wisconsin, Milwaukee, examined the role of children who are acting as caregivers for those diagnosed with amyotrophic lateral sclerosis…

Continue Reading Study Highlights Need to Support Youth Acting as Amyotrophic Lateral Sclerosis Caregivers

Sanofi is Making Strides in Lysosomal Storage Disease Research

Sanofi There are an estimated 350 million rare disease patients across the world. Many conditions still don't have treatments. However, there are scientists dedicating their lives solely to this endeavor.…

Continue Reading Sanofi is Making Strides in Lysosomal Storage Disease Research
Chloroquine was Touted to Treat Coronavirus. Now, This Sjögren’s Syndrome Patient Can’t Find It
source: pixabay.com

Chloroquine was Touted to Treat Coronavirus. Now, This Sjögren’s Syndrome Patient Can’t Find It

According to a story from Buzzfeed News, Sharon Greenstein, who lives with the rare autoimmune disease known as Sjögren's syndrome, can no longer find the drug that she uses for…

Continue Reading Chloroquine was Touted to Treat Coronavirus. Now, This Sjögren’s Syndrome Patient Can’t Find It
New Research Discovers Childhood Neurodegenerative Disorder
https://pixabay.com/en/nerve-cell-neuron-brain-neurons-2213009/

New Research Discovers Childhood Neurodegenerative Disorder

Researchers from the Murdoch Children’s Research Institute (MCRI) have recently discovered a previously unknown and uncharted neurodegenerative disorder. This rare disorder, which has not yet been named, affects children. It…

Continue Reading New Research Discovers Childhood Neurodegenerative Disorder